Universe · entity
GSK plc
Institutional manager (13F) · CIK 1131399
13F holdings · as of 2026-03-31 · top 13 · reported portfolio $599M
| # | Issuer | Value | Shares |
|---|---|---|---|
| 1 | CRISPR THERAPEUTICS AG | $153M | 3,220,627 |
| 2 | WAVE LIFE SCIENCES LTD | $132M | 18,245,691 |
| 3 | BIONTECH SE | $79M | 889,824 |
| 4 | VIR BIOTECHNOLOGY INC | $77M | 8,550,954 |
| 5 | IDEAYA BIOSCIENCES INC | $44M | 1,333,333 |
| 6 | LYELL IMMUNOPHARMA INC | $30M | 1,512,659 |
| 7 | CYTOKINETICS INC | $22M | 340,434 |
| 8 | SPERO THERAPEUTICS INC | $22M | 9,190,606 |
| 9 | FULCRUM THERAPEUTICS INC | $14M | 1,785,714 |
| 10 | CVRX INC | $10M | 1,007,583 |
| 11 | BICYCLE THERAPEUTICS PLC | $7M | 1,529,561 |
| 12 | NKARTA INC | $7M | 3,150,732 |
| 13 | REGENXBIO INC | $2M | 271,456 |
Source: sec_edgar_13f · public regulatory · retrieved 2026-06-29. Public SEC data; no contact information.